1.
MAP kinase pathways in UV-induced apoptosis of retinal pigment epithelium ARPE19 cells
by Roduit, Raphaël
Apoptosis (London), 2008, Vol.13 (3), p.343-353
2.
Brominated flame retardants, tetrabromobisphenol A and hexabromocyclododecane, activate mitogen-activated protein kinases (MAPKs) in human natural killer cells
by Cato, Anita
Cell biology and toxicology, 2014, Vol.30 (6), p.345-360
3.
Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets
by Hommes, D W
Gut, 2003, Vol.52 (1), p.144-151
4.
The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway
by Bravo-San Peo, José M
Cellular and molecular life sciences : CMLS, 2013, Vol.70 (1), p.121-36
5.
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways
by Liu, Weimin, MD
Journal of allergy and clinical immunology, 2008, Vol.121 (4), p.893-902.e2
6.
Activated Ask1-MKK4-p38MAPK/JNK Stress Signaling Pathway in Human Omental Fat Tissue May Link Macrophage Infiltration to Whole-Body Insulin Sensitivity
by Blüher, Matthias
The journal of clinical endocrinology and metabolism, 2009, Vol.94 (7), p.2507-2515
7.
Reactive Oxygen Species in the Activation of MAP Kinases
by Son, Yong
Methods in Enzymology, 2013, Vol.528, p.27-48
8.
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
by Chen, Zhijian J
Nature (London), 2001, Vol.412 (6844), p.346-351
9.
Targeting the RAF–MEK–ERK pathway in cancer therapy
by Montagut, Clara
Cancer letters, 2009, Vol.283 (2), p.125-134
10.
Polar gradients of the DYRK-family kinase Pom1 couple cell length with the cell cycle
by Berthelot-Grosjean, Martine
Nature, 2009, Vol.459 (7248), p.852-856
11.
Tricin, flavonoid from Njavara reduces inflammatory responses in hPBMCs by modulating the p38MAPK and PI3K/Akt pathways and prevents inflammation associated endothelial dysfunction...
by Shalini, V
Immunobiology (1979), 2015, Vol.221 (2), p.137-144
12.
13.
Energy-dependent regulation of cell structure by AMP-activated protein kinase
by Lee, Jun Hee
Nature, 2007, Vol.447 (7147), p.1017-1020
14.
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
by Infante, Jeffrey R, Dr
The lancet oncology, 2012, Vol.13 (8), p.773-781
15.
MST3 kinase phosphorylates TAO1/2 to enable Myosin Va function in promoting spine synapse development
by Ultanir, Sila K
Neuron (Cambridge, Mass.), 2014, Vol.84 (5), p.968-982
16.
p38 MAPK-mediated regulation of Xbp1s is crucial for glucose homeostasis
by Lee, Jaemin
Nature medicine, 2011, Vol.17 (10), p.1251-1260
17.
PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization
by Shin, Incheol
Nature medicine, 2002, Vol.8 (10), p.1145-1152
18.
Mutations in MAP3K7 that Alter the Activity of the TAK1 Signaling Complex Cause Frontometaphyseal Dysplasia
by Wade, Emma M
American journal of human genetics, 2016, Vol.99 (2), p.392-406
20.
LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells
by Zhang, Jian
Cancer letters, 2011, Vol.317 (1), p.24-32
